Wanjia Group Holdings Limited
Research Wanjia Group Holdings Limited (0401.HK) on Bullrun: market cap HKD 113.99M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker0401.HK
- ExchangeHK
- CountryHong Kong
- SectorHealthcare
- IndustryMedical Distribution
- CurrencyHKD
- Market capHKD 113.99M
- Financial periodFY2025
- RevenueHKD 161.69M
- Revenue growth-10.7%
- Net income-HKD 6.62M
- Free cash flowHKD 9.92M
- Gross margin31.1%
Valuation Snapshot
latest market cap is HKD 113.99M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | HKD 161.69M | -HKD 6.62M | HKD 9.92M | 31.1% | -0.01 | HKD 24.08M | HKD 11.72M | HKD 66.88M |
| FY2024 | HKD 181.09M | -HKD 39.98M | HKD 5.89M | 30.2% | -0.06 | HKD 18.23M | HKD 15.60M | HKD 73.49M |
| FY2023 | HKD 173.70M | HKD 1.82M | HKD 5.47M | 32.8% | 0 | HKD 9.88M | HKD 25.17M | HKD 118.20M |
| FY2022 | HKD 154.82M | -HKD 51.00M | -HKD 4.86M | 35.0% | -0.07 | HKD 5.77M | HKD 20.99M | HKD 126.18M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | HKD 113.99M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 HKD.
About Wanjia Group Holdings Limited
Wanjia Group Holdings Limited, an investment holding company, engages in the wholesale and distribution pharmaceutical business in the Mainland China and Hong Kong. The company also offers hemodialysis treatment and consultancy services. It sells its products to hospitals and healthcare institutions; and companies operating pharmaceutical retail chain stores, independent pharmacies, outpatient departments of community hospitals, healthcare service stations, and clinics.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Wanjia Group Holdings Limited's market cap?
Wanjia Group Holdings Limited's market capitalization is HKD 113.99M.
What does Wanjia Group Holdings Limited do?
Wanjia Group Holdings Limited, an investment holding company, engages in the wholesale and distribution pharmaceutical business in the Mainland China and Hong Kong. The company also offers hemodialysis treatment and consultancy services. It sells its products to hospitals and healthcare institutions; and companies operating pharmaceutical retail chain stores, independent pharmacies, outpatient departments of community hospitals, healthcare service stations, and clinics. Wanjia Group Holdings Limited was founded in 2004 and is headquartered in Kowloon, Hong Kong.